Cargando…

The mTOR Inhibitor Rapamycin Counteracts Follicle Activation Induced by Ovarian Cryopreservation in Murine Transplantation Models

Background and Objectives: Ovarian tissue cryopreservation followed by autotransplantation (OTCTP) is currently the only fertility preservation option for prepubertal patients. Once in remission, the autotransplantation of frozen/thawed tissue is performed when patients want to conceive. A major iss...

Descripción completa

Detalles Bibliográficos
Autores principales: Bindels, Jules, Squatrito, Marlyne, Bernet, Laëtitia, Nisolle, Michelle, Henry, Laurie, Munaut, Carine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456585/
https://www.ncbi.nlm.nih.gov/pubmed/37629764
http://dx.doi.org/10.3390/medicina59081474
_version_ 1785096734817386496
author Bindels, Jules
Squatrito, Marlyne
Bernet, Laëtitia
Nisolle, Michelle
Henry, Laurie
Munaut, Carine
author_facet Bindels, Jules
Squatrito, Marlyne
Bernet, Laëtitia
Nisolle, Michelle
Henry, Laurie
Munaut, Carine
author_sort Bindels, Jules
collection PubMed
description Background and Objectives: Ovarian tissue cryopreservation followed by autotransplantation (OTCTP) is currently the only fertility preservation option for prepubertal patients. Once in remission, the autotransplantation of frozen/thawed tissue is performed when patients want to conceive. A major issue of the procedure is follicular loss directly after grafting mainly due to follicle activation. To improve follicular survival during the OTCTP procedure, we inhibited the mTOR pathway involved in follicle activation using rapamycin, an mTOR inhibitor. Next, we compared two different in vivo models of transplantation: the recently described non-invasive heterotopic transplantation model between the skin layers of the ears, and the more conventional and invasive transplantation under the kidney capsule. Materials and Methods: To study the effects of adding rapamycin during cryopreservation, 4-week-old C57BL/6 mouse ovaries, either fresh, slow-frozen, or slow-frozen with rapamycin, were autotransplanted under the kidney capsule of mice and recovered three weeks later for immunohistochemical (IHC) analysis. To compare the ear with the kidney capsule transplantation model, fresh 4-week-old C57BL/6 mouse ovaries were autotransplanted to either site, followed by an injection of either LY294002, a PI3K inhibitor, vehicle control, or neither, and these were recovered three weeks later for IHC analysis. Results: Rapamycin counteracts cryopreservation-induced follicle proliferation, as well as AKT and mTOR pathway activation, in ovaries autotransplanted for three weeks under the kidney capsule of mice. Analyses of follicle proliferation, mTOR activation, and the effects of LY294002 treatment were similar in transplanted ovaries using either the ear or kidney capsule transplantation model. Conclusions: By adding rapamycin during the OTCTP procedure, we were able to transiently maintain primordial follicles in a quiescent state. This is a promising method for improving the longevity of the ovarian graft. Furthermore, both the ear and kidney capsule transplantation models were suitable for investigating follicle activation and proliferation and pharmacological strategies.
format Online
Article
Text
id pubmed-10456585
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104565852023-08-26 The mTOR Inhibitor Rapamycin Counteracts Follicle Activation Induced by Ovarian Cryopreservation in Murine Transplantation Models Bindels, Jules Squatrito, Marlyne Bernet, Laëtitia Nisolle, Michelle Henry, Laurie Munaut, Carine Medicina (Kaunas) Article Background and Objectives: Ovarian tissue cryopreservation followed by autotransplantation (OTCTP) is currently the only fertility preservation option for prepubertal patients. Once in remission, the autotransplantation of frozen/thawed tissue is performed when patients want to conceive. A major issue of the procedure is follicular loss directly after grafting mainly due to follicle activation. To improve follicular survival during the OTCTP procedure, we inhibited the mTOR pathway involved in follicle activation using rapamycin, an mTOR inhibitor. Next, we compared two different in vivo models of transplantation: the recently described non-invasive heterotopic transplantation model between the skin layers of the ears, and the more conventional and invasive transplantation under the kidney capsule. Materials and Methods: To study the effects of adding rapamycin during cryopreservation, 4-week-old C57BL/6 mouse ovaries, either fresh, slow-frozen, or slow-frozen with rapamycin, were autotransplanted under the kidney capsule of mice and recovered three weeks later for immunohistochemical (IHC) analysis. To compare the ear with the kidney capsule transplantation model, fresh 4-week-old C57BL/6 mouse ovaries were autotransplanted to either site, followed by an injection of either LY294002, a PI3K inhibitor, vehicle control, or neither, and these were recovered three weeks later for IHC analysis. Results: Rapamycin counteracts cryopreservation-induced follicle proliferation, as well as AKT and mTOR pathway activation, in ovaries autotransplanted for three weeks under the kidney capsule of mice. Analyses of follicle proliferation, mTOR activation, and the effects of LY294002 treatment were similar in transplanted ovaries using either the ear or kidney capsule transplantation model. Conclusions: By adding rapamycin during the OTCTP procedure, we were able to transiently maintain primordial follicles in a quiescent state. This is a promising method for improving the longevity of the ovarian graft. Furthermore, both the ear and kidney capsule transplantation models were suitable for investigating follicle activation and proliferation and pharmacological strategies. MDPI 2023-08-16 /pmc/articles/PMC10456585/ /pubmed/37629764 http://dx.doi.org/10.3390/medicina59081474 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bindels, Jules
Squatrito, Marlyne
Bernet, Laëtitia
Nisolle, Michelle
Henry, Laurie
Munaut, Carine
The mTOR Inhibitor Rapamycin Counteracts Follicle Activation Induced by Ovarian Cryopreservation in Murine Transplantation Models
title The mTOR Inhibitor Rapamycin Counteracts Follicle Activation Induced by Ovarian Cryopreservation in Murine Transplantation Models
title_full The mTOR Inhibitor Rapamycin Counteracts Follicle Activation Induced by Ovarian Cryopreservation in Murine Transplantation Models
title_fullStr The mTOR Inhibitor Rapamycin Counteracts Follicle Activation Induced by Ovarian Cryopreservation in Murine Transplantation Models
title_full_unstemmed The mTOR Inhibitor Rapamycin Counteracts Follicle Activation Induced by Ovarian Cryopreservation in Murine Transplantation Models
title_short The mTOR Inhibitor Rapamycin Counteracts Follicle Activation Induced by Ovarian Cryopreservation in Murine Transplantation Models
title_sort mtor inhibitor rapamycin counteracts follicle activation induced by ovarian cryopreservation in murine transplantation models
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456585/
https://www.ncbi.nlm.nih.gov/pubmed/37629764
http://dx.doi.org/10.3390/medicina59081474
work_keys_str_mv AT bindelsjules themtorinhibitorrapamycincounteractsfollicleactivationinducedbyovariancryopreservationinmurinetransplantationmodels
AT squatritomarlyne themtorinhibitorrapamycincounteractsfollicleactivationinducedbyovariancryopreservationinmurinetransplantationmodels
AT bernetlaetitia themtorinhibitorrapamycincounteractsfollicleactivationinducedbyovariancryopreservationinmurinetransplantationmodels
AT nisollemichelle themtorinhibitorrapamycincounteractsfollicleactivationinducedbyovariancryopreservationinmurinetransplantationmodels
AT henrylaurie themtorinhibitorrapamycincounteractsfollicleactivationinducedbyovariancryopreservationinmurinetransplantationmodels
AT munautcarine themtorinhibitorrapamycincounteractsfollicleactivationinducedbyovariancryopreservationinmurinetransplantationmodels
AT bindelsjules mtorinhibitorrapamycincounteractsfollicleactivationinducedbyovariancryopreservationinmurinetransplantationmodels
AT squatritomarlyne mtorinhibitorrapamycincounteractsfollicleactivationinducedbyovariancryopreservationinmurinetransplantationmodels
AT bernetlaetitia mtorinhibitorrapamycincounteractsfollicleactivationinducedbyovariancryopreservationinmurinetransplantationmodels
AT nisollemichelle mtorinhibitorrapamycincounteractsfollicleactivationinducedbyovariancryopreservationinmurinetransplantationmodels
AT henrylaurie mtorinhibitorrapamycincounteractsfollicleactivationinducedbyovariancryopreservationinmurinetransplantationmodels
AT munautcarine mtorinhibitorrapamycincounteractsfollicleactivationinducedbyovariancryopreservationinmurinetransplantationmodels